Dermatology Partnering Terms and Agreements

$2,995.00

Publication ID
CPA1214009
Publication Date
December 1, 2014
Pages
981
Regions Covered
Publisher
Current Partnering
The Dermatology Partnering Terms and Agreementsreport provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. 
The majority of deals are marketed stage deals whereby the licensee obtains a marketing right or an option tcmarket or market the licensors dermatology product candidates. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes. 
 
This report provides details of the latest dermatology deals and contracts announced in the healthcare sectors.
 
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases dnot.
 
The report includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. 
The initial chapters of this report provide an orientation of dermatology dealmaking and business activities. Chapter 1 provides an introduction tthe report.
 
Chapter 2 provides an overview of the trends in dermatology dealmaking since 2009 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.
                             
Chapter 3 provides a review of the leading dermatology deals since 2009. Deals are listed by headline value, signed by bigp harma and big biotech and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract.
                                                                       
Chapters 4 and 5 provide a comprehensive listing of the top 50 big pharma and big biotech companies with a brief summary followed by a comprehensive listing of dermatology deals, as well as contract documents available in the public domain. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.
 
Chapter 6 provides comprehensive access tall dermatology deals since 2009 where a deal contract is available, providing the user with direct access tcontracts as filed with the SEC regulatory authorities. Each deal title links via Weblink tan online version of the deal record contract document, providing easy access teach contract document on demand.
 
Chapter 7 provides a comprehensive directory of all dermatology partnering deals by specific therapeutic target announced since 2009. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.
 
In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2009. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.
 
The report alsincludes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2009.     
 
In conclusion, this report provides everything a prospective dealmaker needs tknow about partnering in the research, development and commercialization of dermatology technologies and products.
 

Benefits

Key benefits
 

Dermatology Partnering Terms and Agreementsprovides the reader with the following key benefits:

  • In-depth understanding of dermatology deal trends since 2009
  • Access dermatology deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between dermatology partner companies
  • Comprehensive access tover 750 links tactual dermatology deals entered intby the world’s biopharma companies
  • Indepth review of dermatology deals entered intby the leading fifty bigpharma companies
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner dermatology opportunities
  • Uncover companies actively partnering dermatology opportunities
 

Report scope

Dermatology Partnering Terms and Agreements is intended tprovide the reader with an in-depth understanding and access tdermatology trends and structure of deals entered intby leading companies worldwide.

Dermatology Partnering Terms and Agreements includes:

  • Trends in dermatology dealmaking in the biopharma industry since 2009
  • Analysis of dermatology deal structure
  • Access theadline, upfront, milestone and royalty data
  • Access thundreds of dermatology deal contract documents
  • Comprehensive access tover 750 dermatology deal records
  • The leading dermatology deals by value since 2009
  • Most active dermatology dealmakers since 2009
 

In Dermatology Partnering Terms and Agreements, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication
 
Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

Executive Summary

Chapter 1 – Introduction

 

Chapter 2 – Trends in dermatology dealmaking

2.1. Introduction
2.2. Dermatology partnering over the years
2.3. Big pharma dermatology dealmaking activity
2.4. Big biotech dermatology dealmaking activity
2.5. Dermatology partnering by deal type
2.6. Most active in dermatology partnering
2.7. Dermatology partnering by industry sector
2.8. Dermatology partnering by stage of development
2.9. Dermatology partnering by technology type
2.10. Dermatology partnering by specific therapy indication
2.11. Average deal terms for dermatology
2.11.1 Dermatology headline values by stage of development
2.11.2 Dermatology upfront payments by stage of development
2.11.3 Dermatology milestone payments by stage of development
2.11.4 Dermatology royalty rates by stage of development
 

Chapter 3 – Leading dermatology deals

3.1. Introduction
3.2. Top dermatology deals by value
 

Chapter 4 – Big pharma dermatology deals

4.1. Introduction
4.2. How to use big pharma partnering deals
4.3. Big pharma dermatology partnering company profiles
 

Chapter 5 – Big biotech dermatology deals

5.1. Introduction
5.2. How to use big biotech partnering deals
5.3. Bigbiotech dermatology partnering company profiles
 

Chapter 6 – Dermatology partnering contracts directory

6.1. Introduction
6.2. Dermatology partnering contracts deals directory – by company A-Z
6.3. Dermatology partnering contracts deals directory – by deal type
6.4. Dermatology partnering contracts deals directory - stage of development
6.5. Dermatology partnering contracts deals directory - technology type
 

Chapter 7 – Dermatology dealmaking by therapeutic target

7.1. Introduction
7.2. Dermatology deals by specific therapeutic target
Dermatology
Acne
Actinic keratosis
Angioedema
Burns
Cellulitis
Cosmetics
Dermatitis
Diabetic foot ulcer
Eczema
Hair disorders
Impetigo
Itching
Nail disorders
Psoriasis
Rosacea
Scabies
Sun damage
Symptoms
Venous ulcer
Verruca
Wound healing
Wrinkles
 

Appendices

Appendix 1 – Directory of dermatology deals by company A-Z 2009-2014
Appendix 2 – Directory of dermatology deals by deal type 2009-2014
Appendix 3 – Directory of dermatology deals by stage of development 2009-2014
Appendix 4 – Directory of dermatology deals by technology type 2009-2014
Appendix 5 – Partnering resource center
Online partnering
Partnering events
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering
Order Form – Upgrades to subscription access products
Order Form – Therapy Reports
 

Table of figures

Figure 1: Dermatology partnering since 2009
Figure 2: Big pharma – top 50 – Dermatology deals 2009 to 2014
Figure 3: Big pharma dermatology deal frequency – 2009 to 2014
Figure 4: Big biotech – top 50 – Dermatology deals 2009 to 2014
Figure 5: Big biotech dermatology deal frequency – 2009 to 2014
Figure 6: Dermatology partnering by deal type since 2009
Figure 7: Most active dermatology dealmakers– 2009 to 2014
Figure 8: Dermatology partnering by industry sector since 2009
Figure 9: Dermatology partnering by stage of development since 2009
Figure 10: Dermatology partnering by technology type since 2009
Figure 11: Dermatology partnering by specific dermatology therapy target since 2009
Figure 12: Dermatology deals with a headline value
Figure 13: Dermatology deal headline value distribution, US$million – discovery stage
Figure 14: Dermatology deal headline value distribution, US$million – preclinical stage
Figure 15: Dermatology deal headline value distribution, US$million – phase I stage
Figure 16: Dermatology deal headline value distribution, US$million – phase II stage
Figure 17: Dermatology deal headline value distribution, US$million – phase III stage
Figure 18: Dermatology deal headline value distribution, US$million – regulatory stage
Figure 19: Dermatology deal headline value distribution, US$million – marketed stage
Figure 20: Summary median headline value by stage of development, 2009-2014
Figure 21 Dermatology deals with upfront payment values
Figure 22: Dermatology deal upfront payment distribution, US$million – discovery stage
Figure 23: Dermatology deal upfront payment distribution, US$million – preclinical stage
Figure 24: Dermatology deal upfront payment distribution, US$million – phase I stage
Figure 25: Dermatology deal upfront payment distribution, US$million – phase II stage
Figure 26: Dermatology deal upfront payment distribution, US$million – phase III stage
Figure 27: Dermatology deal upfront payment distribution, US$million – regulatory stage
Figure 28: Dermatology deal upfront payment distribution, US$million – marketed stage
Figure 29: Summary median upfront payments by stage of development, 2009-2014
Figure 30: Dermatology deals with milestone payments
Figure 31: Dermatology deal milestone distribution, US$million – discovery stage
Figure 32: Dermatology deal milestone distribution, US$million – preclinical stage
Figure 33: Dermatology deal milestone distribution, US$million – phase I stage
Figure 34: Dermatology deal milestone distribution, US$million – phase II stage
Figure 35: Dermatology deal milestone distribution, US$million – phase III stage
Figure 36: Dermatology deal milestone distribution, US$million – regulatory stage
Figure 37: Dermatology deal milestone distribution, US$million – marketed stage
Figure 38: Dermatology deals with royalty rates, %
Figure 39: Dermatology deal royalty rate distribution, US$million – discovery stage
Figure 40: Dermatology deal royalty rate distribution, US$million – preclinical stage
Figure 41: Dermatology deal royalty rate distribution, US$million – phase I stage
Figure 42: Dermatology deal royalty rate distribution, US$million – phase II stage
Figure 43: Dermatology deal royalty rate distribution, US$million – phase III stage
Figure 44: Dermatology deal royalty rate distribution, US$million – regulatory stage
Figure 45: Dermatology deal royalty rate distribution, US$million – marketed stage
Figure 46: Summary median royalty rate by stage of development, 2009-2014
Figure 47: Top dermatology deals by value since 2009
Figure 48: Online partnering resources
Figure 49: Forthcoming partnering events
21 Medical Technologies,3M,3M Critical & Chronic Care Solutions,4SC,AAP Implantate AG,Abbott Laboratories,Academy Medical,Access Pharmaceuticals,ACE Surgical Supply,Acell,Acella Pharmaceuticals,Actavis,Actavis (acquired by Watson),Actelion,ADB International Group,Adcock Ingram,Ade Therapeutics,AdeTherapeutics,ADVANCE Medical,Advanced Bio-Technologies,Advanced Biohealing,Advanced Biosciences Research,Advanced Medical Solutions,Advanced Plasma Products,Advanced Viral Research,Aero Pharmaceuticals,AET Biotech,Aethlon Medical,Affinium Pharmaceuticals,Affirmative Solutions,Afinity Life Sciences,Airmid,AJS Enterprises,Akrikhin,Albany Molecular Research,ALDA Pharmaceuticals,Alfa Medica,AlgiPharma,ALK-Abello,Allergan,AllerQuest,Alliance Pharma,Allied Minds,Alliqua Biomedical,Alma Lasers,Almac Group,Almirall,Alphaeon,Alpharx,Alto Pharmaceuticals,AltrazealTrading,Amarantus BioSciences,Ambu,AMD Ritmed,AmDerma Pharmaceuticals,American Breast Cancer Foundation,American CryoStem,American Peptide Company,American Red Cross,Amerx Health,Amgen,Amkor,Amneal Enterprises,Amway Global,Amyris Biotechnologies,Ana Darou,Anacor Pharmaceuticals,Andrew Technologies,AndroScience,Angel Biotechnology,AnGes MG,Angion Biomedica,Angiotech Pharmaceuticals,Anika Therapeutics,Antares Pharma,Anteis,AOTI,Apeiron Biologics,Apex Medicus,APR Applied Pharma Research,Aqua Pharmaceuticals,Aquavit Pharmaceuticals,Aratana Therapeutics,Arena Pharmaceuticals,Argentum Medical,Argyle Therapeutics,Argyll Biotechnologies,Ark Therapeutics,Armed Forces Institute of Regenerative Medicine (AFIRM),Arteriocyte Medical Systems,ASD Speciality Healthcare,Astellas Pharma,AstraZeneca,Atopix,Atrium Medical,Aurora Biosciences,Austen BioInnovation Institute in Akron (ABIA),Autogenesis,Auven Therapeutics,Avery Dennison,Avidas Pharmaceuticals,Avita Medical,Avita Medical MENA,AvKARE,Axxess Pharma,Azelis,Azopharma,B Braun,Bachem,BASF,Basilea Pharmaceutica,Battelle,Bavarian Nordic,Baxter International,Bayer,Bayer Animal Health,Bayer Healthcare,BC Cancer Agency,Beacon Pharmaceuticals,Beeken BioMedical,Beijing Wenfeng Tianji Pharmaceuticals,Bellus Health,Bend Research,Benelux Cosmetics,BexPharm,BHIP Global,Bimini Technologies,BioAtla,BioChemics,Biocodex,BioDlogics,BioElectronics,BioFocus,Biofrontera Pharma,Biogalenys,Biogen Idec,Biogenics,BioMedica Life Sciences,Biomedical Advanced Research and Development Authority,Biomedical Catalyst Fund (UK),Biomerica,BioMotiv,BioNeutral,Bioniche Life Sciences,BiopharmX,BioPro Pharmaceutical,Biosara,BiosCompass,Biostar Pharmaceuticals,Biostem US,BioSyent Pharma,BioTech Medics,Biotest,Biothera,BioTime,BioTime Asia,Biovail,Biovail Laboratories,BioXpress,BioZone Laboratories,BioZone Pharmaceuticals,BMG Pharmaceuticals,Bracco Diagnostics,Brennen Medical,Brickell,Bristol-Myers Squibb,Brown University,BSN Medical,Bupa,CA BOTANA,Caleco Pharma,Caleco Pharma Europe,Caliber Imaging & Diagnostics,Calysta Energy,Cambrex,CAN-med Healthcare,CanAm Care,Canderm Pharma,Cannabis Science,Cantel Medical (UK),CardioVascular BioTherapeutics,Cardium Therapeutics,CareFusion,Carolon,Case Western Reserve University,CDx Diagnostics,Ceapro,Celgene Cellular Therapeutics,Cellceutix,Cellogique,Central Medical Systems,Centric Research Institute,Ceragenix Pharmaceuticals,Ceres Living,Certara,CHAMPS Group Purchasing,Charite-Universitatsmedizin,ChartLogic,Chesson Labs,Chitinor,ChromaDex,Cilag AG,Cimtech,Cincinnati Children’s Hospital Medical Center,Cipher Pharmaceuticals,Circassia,Clinipace Worldwide,Clinuvel Pharmaceuticals,CMIC,Cobra Biologics,CoDa Therapeutics,Collagenna Skin Care Products,Collegium Pharmaceuticals,Columbia University,Combat Medical Systems,Combe,Comercial Uni2,Comercializadora Almed,Comvita New Zealand,ConBio (Shanghai),ConvaTec,Convoy Therapeutics,Cornerstone Therapeutics,Covalon Technologies,Covance,Crawford Healthcare,Crawford Woundcare,CROMA Pharma,Cryo-Cell International,Curetis,Cutanogen,Cutera,Cynosure,Cytomedix,Cytori Therapeutics,CytoSolv,CytoSorbents,Czech Republic Institute of Experimental Botany,Daewoong Pharmaceutical,Dalpharma,Dalton Pharma Services,DARA BioSciences,DATATRAK International,Daxor,Defense Advanced Research Projects Agency,Defiante Farmaceutica,Department of Defense,Derma Sciences,Dermactye Switzerland,DermaGenoma,Dermaventures,Dermira,DermTech,Desitin,Destum,Devon Medical Products,Devro Medical,DiFUSION,Digirad,Digna Biotech,Dimethaid Research,Dipexium Pharmaceuticals,DPT Laboratories,DS Healthcare,DSG Partners,DSM,Dukal,Duoject Medical Systems,Dupetit Natural Products,Durata Therapeutics,DUSA Pharmaceuticals,Dyadic Netherlands,Dyax,Dynavax Technologies,Easton Pharmaceuticals,Echo Therapeutics,ECI Biotech,ECR Pharmaceuticals,Eden Biodesign,Efe Consultoria & Importacao Ltda,Effimune,Elder Healthcare,Eleme Medical,Eloquest Healthcare,Elorac Pharma,Emergent BioSolutions,Endo Pharmaceuticals,Enterade,Envy Medical,Epistem,EquinoxO2 Medical,Equity Labs,Esteve,Eterna,Ethicon Endo-Surgery,EU AIMS,European Commission,EUSA Pharma,Evergreen Marketing,Evolva,Evonik Degussa,Exciton Technologies,Faes Farma,Ferndale Healthcare,Ferndale Pharmaceuticals,Ferrer International,Fibrocell Science,First Choice Cooperative,Fischer Pharmaceutical,Flamel Technologies,Flemish agency for Innovation by Science and Technology,Flextronics,FMC,Foamix,Focus Product Development,Food and Drug Administration (FDA),Forest Laboratories,Fourth Military Medical University,Fovea Pharmaceuticals,FTA Therapeutics,Fullife Healthcare,G-treeBNT,Galapagos,Galderma,Gebro Pharma,GeneLink Biosciences,General Biologicals,Genfa Medica,GeNOsys,German Medical Engineering,Gideon Pharmaceuticals,Givaudan,GlaxoSmithKline,Glenmark Pharmaceuticals,GliaMed,Government of Australia,Graceway Pharmaceuticals,Grant Industries,Green Molecular,Greyson International,Grupo Angelini,Grupo Juste,Guangzhou Xiangxue Pharmaceutical,GVK Biosciences,Hackensack University Medical Center,Haemacure,Halozyme Therapeutics,Hanwha Chemical,Hapten Sciences,Hartmann,Harvest Biotech,Healing Innovation,Healogics,Healthpoint,Healthpoint Biotherapeutics,Helicon Group,Helix BioMedix,HelixLife,HemCon Medical Technologies,Hengdian,Henry Schein,HepaLife,Heraeus,Herapharm,Herborium,Hi-Tech Pharmacal,Histogen,Histostem,Hitit Medical Systems,Hollister-Stier Labs,Horizon Pharma AG,Hospira,HOYA Corporation,Huapont Pharma,Hugel,Humeca,Hurel,Hygeia Therapeutics,Hyup Jin Corporation,Icahn School of Medicine at Mount Sinai,IGI Laboratories,Iluminage,Iluminage Beauty,Imaginative Research Associates,Imbed Bio,ImmanenceIntegrale Dermo Correction,ImmuDyne,Immune Response BioPharma,ImmuneRegen BioSciences,Immunocorp Consumer Health,Immunocorp Inc,Immunosyn,Impax Laboratories,Imprimis Pharmaceuticals,Incisive Surgical,Industria Farmaceutica Andromaco,Injex Pharma,Innocoll,Innocutis,Innovative Therapies,Innovus Pharmaceuticals,Institute for In Vitro Sciences,Institute for Systems Biology,Instrumentacion,Intas Biopharmaceuticals,Integrated Commercialization Solutions,Integrated Healing Technologies,IntelliCell BioSciences,Intendis,Intercytex,International Stem Cell,Intrexon,Intronix Technologies,Invacare,InVentiv Health,Invida Holdings,Invida Pharmaceuticals,InVivo Therapeutics,Iridex,IrriMax,Isodiagnostika,Isotechnika Inc,Isotechnika Pharma,ITEM Medical Technologies,Itochu,Jan Marini Skin Research,Janssen Biotech,Janssen Pharmaceutica NV,Janssen Pharmaceuticals,Japan Tobacco,Jcom,JD Nelson and Associates,JH Direct,Jiangxi Aiqilin Pharmaceuticals,Johns Hopkins University,Johnson & Johnson Consumer Companies,Johnson & Johnson Innovation,Juventio,KAHR Medical,Kane Biotech,Karo Bio,Karyopharm Therapeutics,Kasiak,Katholieke University,KCR,Kerecis,Keystone Research and Pharmaceuticals,Kinetic Concepts,KLOX Technologies,Kotra Pharma,Kowa,Kreara Solutions,Kringle Pharma,Kuros Biosurgery,KV Pharmaceutical,Kyowa Hakko Kirin,Kythera Biopharmaceuticals,La Jolla Pharmaceutical,Laboratorio EDOL Produtos Farmaceuticos,Laboratorios Andromaco,LaRon Pharma,LaserGen,Le Metier de Beaute,Lee's Pharmaceutical,Lemmy's Global Markets Nig,LEO Pharma,Leosons General Trading Company,Lescarden,Levlad,Libbs Farmaceutica,LifeCell,Lifeline Skin Care,Ligand Pharmaceuticals,LINC Medical Systems,List Biological Laboratories,Living Cell Technologies,Living Proof,Lonza,Loreal,Lotus Tissue Repair,LR R&D,LSO Medical,Lubrizol,Lumenis,Lundbeck,Lupin,Lupin Limited,Lupin Pharmaceuticals,Luqa Pharmaceuticals,Lycera,Maco Pharma,MacroCure,Madam Therapeutics,Mann and Schroder,MannKind Biopharmaceuticals,Marketing Media Enterprises,Maruho,Massachusetts General Hospital,Mayquest Pharmaceuticals,Mazaya Scientific Bureau,McComb Foundation,McCoy Enterprises,McNeil Consumer Pharmaceuticals,Med-Pharmex,Meda,MedEfficiency,Medi-Tech International,Medical Futures,Medicareplus International,Medicis Pharma,Medidata Solutions,MediGene,Medimetriks,Medipurpose,Medivir,MediWound,Medline Industries,MedPharm,MedTrade Products,Medtronic,Medx,Medy-Tox,Medytox,Megapharm,Meiji Seika,Melmed,MENA United,Menarini Asia-Pacific,Mercachem,Merck and Co,Merck KGaA,Merck Sharpe & Dohme,Merus,Merz,Metanium,Metier Tribeca,Mid-Atlantic Group Network of Shared Services,Milestone Advanced Cosmetic Systems,Milestone China,Milestone Scientific,Millennia Holdings,Millennium Medical Devices,Millipore,MiMedx,Misonix,Mission Pharmacal,Mitsubishi Tanabe Pharma,Moberg Pharma,Molecular Botanicals,Molecular Profiles,Molnlycke Health Care,Mor Research Applications,More Pharma,MP Biomedicals,MPI Research,MTG Medical,Mundipharma,Mylan Laboratories,NanoBio,Nanotherapeutics,Naqu Area Pioneer Pharma,National Cancer Institute,National Distribution & Contracting,National Health Service,National Institute for Food and Drug Control,National Institute of Allergy and Infectious Diseases,National Institute of Arthritis and Musculoskeletal Diseases,National Institute of Diabetes and Digestive and Kidney Diseases,National Institute of General Medical Sciences,National Institute on Drug Abuse (NIDA),National Institutes of Health,National Psoriasis Foundation,National Science Foundation,National University of Ireland, Galway (NUI Galway),NeoStem,NeoStrata,Nestle,NeutriSci International,New York University,Nexvet,Noble Biomaterials,Norgesplaster,North Med,Norwegian Research Council,Notlers,NovaBay Pharmaceuticals,NovaBiotics,Novadaq Technologies,Novan,Novartis,Novartis Animal Health,Novation,Novellus Biopharma,Nu Skin Enterprises,NuGlow Cosmaceuticals,Numoda,Nutech Medical,Nuvilex,Nuvo Research,NuvoLase,Nxstage Medical,Nycomed,Nycomed US,NYU Medical Center,Oasix,Oat Cosmetics,Obagi Medical Products,Oclaro,Oculus Innovative Sciences,Ohio State University,Ohr Cosmetics,Ohr Pharmaceuticals,OmegaGenesis,Omni Medical Products,Omnio Healer,One Equity Partners,Ono Pharmaceutical,Onset Dermatologics,Onyx Pharmaceuticals,Optigenex,Optovue,Oragenics,Orbsen Therapeutics,Orca Pharmaceuticals,Oregon Health Sciences University,Organogenesis,Orient EuroPharma,Orient Pharma,OroScience,Ortho Dermatologics,Orthobiotiki holdings,Ovation Pharmaceuticals,Oxygen Biotherapeutics,OzHealth Pharma,Pacgen Biopharmaceuticals,Pacific Pharmaceutical,Paddock Laboratories,Paladin Labs,Pantec Biosolutions,ParaPRO,Paratek Pharmaceuticals,Parcell Laboratories,Parios Regenerative Sciences,Parnell Pharmaceutical Holdings,Particle Sciences,PDI,Pediapharm,Pegasus Biologics,PerkinElmer,Pernix Therapeutics,Perrigo,Pfizer,Pharmacopeia,PharmaMar,Pharmaplan,Pharmaplast,Pharming Group,Phenex,Phosphagenics,PhotoMedex,Phusion Laboratoies,Phylogica,Pinnaclife,Pioneer Pharma,Pizzaro Hair Restoration Clinic,PKUcare BeiYi Pharmaceutical,Plandai Biotechnology,Pluristem Therapeutics,Politec Saude,Polyheal,Polymun Scientific Immunbiologische,Polypeptide Laboratory,Polytherapeutics,PPD,Prasco Laboratories,PreCision Dermatology,Premier Healthcare Alliance,Premier Inc,Premier Purchasing Partners,Prestium Pharma,Prime Pharma,Principle Business Enterprises,Procter & Gamble,ProGDerm,Prollenium Medical Technologies,Promius Pharma,Prospector Capital Partners,Protein Genomics,Proteoderm,Proteonomix,ProtoKinetix,Provectus Biopharmaceuticals,Proxy Biomedical,Psychemedics,PURE Bioscience,QLT,Quantitative Solutions,Queensland University of Technology,Quest PharmaTech,Quick Med Technologies,Quigley Corporation,Quinnova Pharmaceuticals,Quintiles,QVC,Ranbaxy Laboratories,Reckitt Benckiser,Recordati,Regenerative Solutions Limited,Regenerx,Regenicin,Remedent,Renaissance Acquisition Holdings,Replicel Life Sciences,ResolutionMD,Revance Therapeutics,RHEI Pharmaceuticals,Riso Pharma,Rivers Edge Pharmaceuticals,Roche,Rodan and Fields,Roger Williams Medical Center,Romaco,Romed,Rose U,RRD International,RubyDerm,Russian Nanotechnology Corporation,RXi Pharmaceuticals,S*Bio,SA MA Technologies,Salon Only Sales,Salon Services & Supplies,Sana Pharma,SanderStrothmann,Sangui BioTech,Sanguin Blood Supply Foundation,Sanofi-Aventis,Sanofi-Aventis Canada,Sanofi-Pasteur,Sanofi,Santalis Pharmaceuticals,Santarus,Sanuwave Health,Sarasota Medical Products,SastoMed,Savant HWP,ScandiDerma,Scholz,SCIderm,SciDerma,Scottish Government,Scripps Research Institute,Seagarden,Select Medical,Semprus BioSciences,Senetek,Sentrx,Sephora,SerenaGroup,Shalaks Pharmaceuticals,Shanghai Institute of Pharmaceutical Industry,Shaw Han,Shenzhen Celestial Pharmaceuticals,Shionogi,Shire Pharmaceuticals,Shiseido,Shoppers Drug Mart,Sidroc Services,Signum Dermalogix,Sinclair IS Pharma,Sinclair Pharmaceuticals,Sinopharm,SINTEF,Sirnaomics,Sirona Biochem,SkinMedica,Skinvera,Skinvisible,Small Caps Finance,Smart Cell Tec,Smith & Nephew,Smith Medical Partners,Snyder Wound Research Institute,Sol-Gel,Solazyme,Solgar Vitamin and Herb,Soliance,Solon Manufacturing,Solvay,Sorin Group,Sound Surgical Technologies,Southern New England Ear, Nose, Throat and Facial Plastic Surgery Group,Space NK,Spear Pharmaceuticals,Spherix,Spiracur,Spirig Pharma,Spring Creek Capital,Stanford University School of Medecine,Starpharma,SteadMed Medical,Stem Cell Therapy,StemNext,Steridose,Stiefel Laboratories,Stopler,Strakan,Stratatech,Stratpharma,Sumitomo Corporation,Sumitomo Corporation Korea,Summit Pharmaceuticals,Sun Pharmaceutical,Suneva Medical,Sunnybrook Health Sciences Centre,SurModics,Suzhou Connect Biopharmaceuticals,Swati Spentose,Swedish Orphan Biovitrum,Sweis,Sylphar,Synapse Microcurrent,SynCore Biotechnology,Synedgen,Synergy Pharmaceuticals,Syneron Beauty,Syneron Medical,Synovis Life Technologies,Synthes,Syntopix,Systagenix Wound Management,T-Ray Science,Taiba,Taro Pharmaceuticals,Taureon,Team Distributing International,Technical Communities,Technology Strategy Board (UK),Telormedix,TEOXANE Laboratories,Tetra Medical Supply Corp,Teva-tuteur,Teva Pharmaceutical Industries,The Salon Center,Therapeutics Incorporated,Thesan Pharmaceuticals,Thornton & Ross,TI Pharma,Tissue Regeneration Therapeutics (TRT),Tissue Repair,Tissue Therapies,Tissuemed,Topica Pharmaceuticals,Toptica Photonics,Toray,Transdel Pharmaceuticals,Transderm,TransMedia,Transmedic,Triax Pharmaceuticals,TRIGOcare,TriStar,Trius Therapeutics,Tufts University,Tyco Healthcare,Tytex,U-Bio Med,UCB,UDL Laboratories,Ueno,Uluru,Unicep Packaging,Unilever Ventures,Univar,University Medical Pharmaceuticals,University of Arizona,University of California, San Diego,University of California Irvine,University of Dundee,University of Hertfordshire,University of Manchester,University of Maryland,University of Medicine and Dentistry of New Jersey,University of Michigan,University of Minnesota,University of Pennsylvania,University of Pittsburgh Medical Center,University of Southern California,University of Texas Southwestern Medical Center,University of Toronto,University of Zurich,Unomedical,US Army,US Army Medical Research and Material Command,US Army Telemedicine and Advanced Technology Research Center (TATRC),US Bioservices,US Biotest,US Department of Veteran Affairs,US Government,US Veterans Administration,V&M Industries,Valamed,Valeant Canada Limited,Valeant Pharmaceuticals,Valeo Pharma,Valocor Therapeutics,Valor Biotherapeutics,Vancive Medical Technologies,VBL Therapeutics (dba),VetCure,ViaCord,Vinnova,Virginia Commonwealth University,Viridis BioPharma,ViroBay,Viropharma,ViroXis,WaferGen Biosystems,Wake Forest University,Walgreens,Walter Reed Army Institute of Research,Watson Laboratories,Watson Pharmaceuticals,Welichem Biotech,Wirthlin-Denton,Womens Choice Pharmaceuticals,World Health Industries,Wound Care Innovations,Wound Management Technologies,WOUNDCHEK Laboratories,Wright Medical,Xijing Hospital,XTL Biopharmaceuticals,Yale University,Yes Biotech,YesDTC,YL Biologics,Yoshindo,Z-Medica,Zelmic,Zeltiq Aesthetics,Zeria Pharmaceuticals,Ziarco Pharma,Zoetis,Zymes
How to buy market research report?
 

Process to buy a market research report from us

Step 1: Select publication license from Publication Type dropdown.
Step 2: Click Add To Cart button.
Step 3: The report is added to your cart and you are redirected to cart page.
Step 4: Enter Coupon Code (if applicable) and click on Apply to order button.
Step 5: Review your cart and either click on Checkout button to proceed or click on Checkout with PayPal button for Express Checkout. Please note PayPal option is not available for buyers from India.
Step 6: Enter your E-mail Address and choose your desired Username and Password for a new account or login with your existing account.
Step 7: Enter your Billing Information.
Step 8: Choose your Payment Method from either 2Checkout (default option) or PayPal and click on Review order button.
Step 9: Review your order and click on Submit order button to go to payment gateway and make payments.
Step 10: You can change your language and currency if you have selected 2Checkout as your payment option. Your billing information is pre-filled, so you can proceed to Payment Method tab.
Step 11: Enter your Credit/Debit Card details and click Submit Payment button to make payment and complete purchase process.
 
Please contact us if you need an Invoice or any other information regarding purchase process.

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
11 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

SINGLE USER LICENSE (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Global License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

SITE USER LICENSE (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Global License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

GLOBAL USER LICENSE (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Note: Product cover images are only for representative purpose only and may vary from those shown above.

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Related Market Research Reports

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data